clinical medicine

临床医学
  • 文章类型: Journal Article
    当目标是帮助患者提高生活质量时,直接关注对每个患者最重要的活动和关系是有意义的。这可以通过以下三个步骤来最有效地完成,包括1)与患者联系,2)共同创建以目标为导向的计划,和3)与病人合作,家庭,团队成员,和顾问来增加成功的概率。一旦掌握了这种方法和必要的系统,进程,关系已经到位,这不应该比面向问题的方法花费更多的时间,几乎可以肯定,这对医生和患者来说都会更令人满意。对基于人群的质量指标的影响是不确定的。尽管更少的患者可能会选择遵循标准建议,那些这样做的人可能更有可能坚持他们。
    When the goal is to help patients improve their quality of life, it makes sense to focus directly on the activities and relationships that are most important to each patient. This can be accomplished most effectively by following a three-step process that includes 1) connecting with the patient around what matters to them, 2) co-creating a goal-oriented plan, and 3) collaborating with patient, family, team members, and consultants to increase the probability of success. Once this approach has been mastered and the necessary systems, processes, and relationships are in place, this should not take more time than a problem-oriented approach, and it will almost certainly be more satisfying for both physician and patient. The impact on population-based quality metrics is uncertain. Though fewer patients may choose to follow standard recommendations, those who do may be more likely to adhere to them.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    DeRitis比率,定义为血清天冬氨酸转氨酶(AST)与丙氨酸转氨酶(ALT)的比值,是一种广泛认可的生化标志物,在诊断和管理各种疾病方面具有重要应用,尤其是肝脏疾病。这篇综合综述综合了当前关于DeRitis比率临床相关性的知识,审视其历史发展,诊断实用程序,以及各种医疗条件下的预后意义,包括肝脏疾病,心血管疾病,和肌肉病理。通过对几十年来的文献的深入分析,这篇综述强调了DeRitis比值不仅在鉴别诊断中的作用,而且作为疾病进展和患者结局的预后指标.该比率能够区分不同类型的肝脏病理,帮助早期疾病检测,并讨论了其在监测治疗反应中的潜在用途。此外,审查涉及方法上的考虑,如混杂因素和口译挑战,影响DeRitis比率的临床效用。鉴于临床诊断的发展和对个性化医疗的推动,审查最后提出了进一步研究的建议。这些包括纵向研究,以探索该比率随时间的变化,跨不同人群的比较研究,和技术集成,以提高诊断准确性和病人护理。这篇综述旨在重申DeRitis比率在现代临床实践中的重要性,并鼓励继续探索其在医疗保健中的潜在应用和益处。
    The De Ritis ratio, defined as the serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio, is a widely recognized biochemical marker with significant applications in diagnosing and managing various diseases, particularly liver disorders. This comprehensive review synthesizes current knowledge surrounding the clinical relevance of the De Ritis ratio, examining its historical development, diagnostic utility, and prognostic significance across various medical conditions, including liver diseases, cardiovascular disorders, and muscular pathologies. Through an in-depth analysis of literature spanning several decades, this review highlights the role of the De Ritis ratio not only in differential diagnosis but also as a prognostic indicator for disease progression and patient outcomes. The ratio\'s ability to distinguish between different types of liver pathology, aid in early disease detection, and its potential use in monitoring treatment response are discussed. Additionally, the review addresses the methodological considerations, such as confounding factors and interpretation challenges, that impact the clinical utility of the De Ritis ratio. Given the evolving landscape of clinical diagnostics and the push toward more personalized medicine, the review concludes with recommendations for further research. These include longitudinal studies to explore the ratio\'s changes over time, comparative research across diverse populations, and technological integration to enhance diagnostic accuracy and patient care. This review aims to reaffirm the importance of the De Ritis ratio in modern clinical practice and encourages continued exploration into its potential applications and benefits in healthcare.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:药物配伍禁忌,药物错误的重要子集,在药物管理阶段威胁患者安全。尽管药物配伍禁忌的患病率很高,目前对此了解甚少,因为以前的研究主要集中在重症监护病房(ICU)设置上.为了提高病人的安全,从全面的角度扩大我们对这个问题的理解至关重要。本研究旨在通过分析医院范围内的处方和管理数据来调查药物配伍禁忌的患病率和机制。
    方法:这项回顾性横断面研究,在三级学术医院进行,包括从研究机构的临床数据仓库中提取的2021年1月1日至2021年5月31日期间收治的患者数据。使用研究现场临床工作流程鉴定药物对(PC)中的潜在接触。每个PC的药物不相容性通过使用商业药物不相容性数据库来确定,Trissel™2临床药物数据库(Trissel2数据库)。确定了药物不相容的驱动因素,基于描述性分析,之后,采用多因素logistic回归分析评估入院时出现一种或多种药物不相容性的危险因素.
    结果:在30,359例患者中(代表40,061例住院),分析了24,270例患者(32,912例住院)和764,501例药物处方(1,001,685例IV给药),检查合格后。根据确定PC的规则,确定了5,813,794例PC。其中,25,108(0.4%)例不兼容的PC:在处方过程中发生了391(1.6%)PC,在给药过程中发生了24,717(98.4%)PC。通过对这些结果进行分类,我们确定了以下导致药物配伍不良的驱动因素:不正确的顺序因素;不正确的给药因素;缺乏相关研究.在多变量分析中,男性患者遇到不相容的PC的风险更高,年长的,更长的停留时间,伴随着更高的合并症,并进入医疗重症监护室。
    结论:我们通过分析医院范围内的药物处方和管理数据,全面描述了药物不兼容的现状。结果表明,在临床环境中经常发生药物不相容。
    OBJECTIVE: Drug incompatibility, a significant subset of medication errors, threaten patient safety during the medication administration phase. Despite the undeniably high prevalence of drug incompatibility, it is currently poorly understood because previous studies are focused predominantly on intensive care unit (ICU) settings. To enhance patient safety, it is crucial to expand our understanding of this issue from a comprehensive viewpoint. This study aims to investigate the prevalence and mechanism of drug incompatibility by analysing hospital-wide prescription and administration data.
    METHODS: This retrospective cross-sectional study, conducted at a tertiary academic hospital, included data extracted from the clinical data warehouse of the study institution on patients admitted between January 1, 2021, and May 31, 2021. Potential contacts in drug pairs (PCs) were identified using the study site clinical workflow. Drug incompatibility for each PC was determined by using a commercial drug incompatibility database, the Trissel\'s™ 2 Clinical Pharmaceutics Database (Trissel\'s 2 database). Drivers of drug incompatibility were identified, based on a descriptive analysis, after which, multivariate logistic regression was conducted to assess the risk factors for experiencing one or more drug incompatibilities during admission.
    RESULTS: Among 30,359 patients (representing 40,061 hospitalisations), 24,270 patients (32,912 hospitalisations) with 764,501 drug prescriptions (1,001,685 IV administrations) were analysed, after checking for eligibility. Based on the rule for determining PCs, 5,813,794 cases of PCs were identified. Among these, 25,108 (0.4 %) cases were incompatible PCs: 391 (1.6 %) PCs occurred during the prescription process and 24,717 (98.4 %) PCs during the administration process. By classifying these results, we identified the following drivers contributing to drug incompatibility: incorrect order factor; incorrect administration factor; and lack of related research. In multivariate analysis, the risk of encountering incompatible PCs was higher for patients who were male, older, with longer lengths of stay, with higher comorbidity, and admitted to medical ICUs.
    CONCLUSIONS: We comprehensively described the current state of drug incompatibility by analysing hospital-wide drug prescription and administration data. The results showed that drug incompatibility frequently occurs in clinical settings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    神话和古印度医学的融合,尤其是阿育吠陀,是文化遗产和科学努力的迷人综合。阿育吠陀包括广泛的实践,包括药理学,解剖学,生理学,手术,和产科,融合了丰富的印度教神话挂毯,提供对健康和疾病的全面了解。将神话人物和叙事纳入古印度医学的话语中,为精神知识和经验知识的融合提供了独特的视角,强调神话在塑造临床医学基本原则中的作用。论述探讨了阿育吠陀及其神话基础对当代临床实践的深刻影响,强调古代叙事中永恒的智慧。这些故事代表了整体医疗实践的基石,强调心灵之间的平等,身体,和精神在现代治疗范式中越来越得到验证。在Sushruta和Charaka的古老文本中详细介绍的哲学和方法,再加上Dhanvantari和Bharadwaja的寓言故事,对支撑当今整体医学方法的基本原则做出了重大贡献。阿育吠陀的持久遗产及其神话叙事继续影响并激发了医疗保健的整体方法,强调古代智慧与现代医学实践之间不可磨灭的联系。
    The fusion of mythology and ancient Indian medicine, particularly Ayurveda, is a fascinating synthesis of cultural heritage and scientific endeavor. Ayurveda encompasses a wide range of practices, including pharmacology, anatomy, physiology, surgery, and obstetrics, and integrates the rich tapestry of Hindu mythology, providing a comprehensive understanding of health and disease. The inclusion of mythological figures and narratives in the discourse of ancient Indian medicine offers a unique perspective on the integration of spiritual and empirical knowledge, highlighting the role of mythology in shaping the foundational principles of clinical medicine. The discourse explores the profound impact of Ayurveda and its mythological underpinnings on contemporary clinical practices, underscoring the timeless wisdom embedded in ancient narratives. These stories represent the bedrock of holistic medical practices, emphasizing the parity between mind, body, and spirit that is increasingly validated in modern therapeutic paradigms. The philosophy and methods detailed in the age-old texts of Sushruta and Charaka, coupled with the allegorical tales of Dhanvantari and Bharadwaja, contribute significantly to the foundational principles underpinning today\'s holistic medical approaches. The enduring legacy of Ayurveda and its mythological narratives continues to influence and inspire a holistic approach to health care, underscoring the indelible connection between ancient wisdom and modern medical practices.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本文分析了与AI和机器学习系统在医学科学和实践中的应用问题相关的出版物数据。特别关注人工智能在医疗保健中的应用要点:诊断,远程医疗,开发新的药物,医疗康复和管理决策过程。尽管在临床实践和制药行业中应用给定系统的广泛观点,有许多尚未解决的问题,例如确保信息安全,做出错误决定的风险和改变现有医疗保健规范法律基础的必要性。
    The paper analyses publications data related to issues of application of AI and machine learning systems in medical science and practice. The particular attention is paid to key points of AI application in health care: diagnostics, telemedicine, development of new medications, medical rehabilitation and management decision-making process. Despite broad perspectives of applying the given systems in clinical practice and pharmaceutical industry, there are a number of such unsolved problems as ensuring information security, risk of making erroneous decisions and necessity to change existing normative legal base of health care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:医疗保健专业人员很少接受患者所依赖的数字技术培训。因此,从业者在为经历数字介导的伤害的患者提供护理时可能面临重大障碍(例如,医疗设备故障和网络安全利用)。这里,我们探讨了技术失败对临床的影响。
    目的:我们的研究探讨了一线医护人员在数字事件中面临的主要挑战,发现临床培训和指导方面的差距,并提出了一套改进数字临床实践的建议。
    方法:一项包括52名参与者的为期1天的研讨会的定性研究,国际出席,多方利益相关者的参与。参与桌面练习和小组讨论的参与者专注于技术复杂的医疗场景(例如,呼吸机故障和医疗保健应用程序上的恶意黑客攻击)。对5位抄写员的大量注释进行了回顾性分析,并进行了主题分析以提取和综合数据。
    结果:临床医生报告了与技术相关的新型伤害形式(例如,家庭暴力中的地理围栏和与相互关联的胎儿监测系统相关的错误)和阻碍不良事件报告的障碍(例如,时间限制和死后设备处置)。提供有效患者护理的挑战包括缺乏对设备故障的临床怀疑,不熟悉设备,缺乏数字定制的临床方案。与会者一致认为,网络攻击应被归类为重大事件,重新利用现有的危机资源。患者的治疗取决于技术在临床管理中的作用,因此,那些依赖可能受损的实验室或放射设施的优先考虑。
    结论:这里,我们通过临床镜头构建了数字事件,描述了它们对患者的终点影响。在这样做的时候,我们制定了一系列建议,以确保对数字事件的反应符合临床需求和中心患者护理.
    BACKGROUND: Health care professionals receive little training on the digital technologies that their patients rely on. Consequently, practitioners may face significant barriers when providing care to patients experiencing digitally mediated harms (eg, medical device failures and cybersecurity exploits). Here, we explore the impact of technological failures in clinical terms.
    OBJECTIVE: Our study explored the key challenges faced by frontline health care workers during digital events, identified gaps in clinical training and guidance, and proposes a set of recommendations for improving digital clinical practice.
    METHODS: A qualitative study involving a 1-day workshop of 52 participants, internationally attended, with multistakeholder participation. Participants engaged in table-top exercises and group discussions focused on medical scenarios complicated by technology (eg, malfunctioning ventilators and malicious hacks on health care apps). Extensive notes from 5 scribes were retrospectively analyzed and a thematic analysis was performed to extract and synthesize data.
    RESULTS: Clinicians reported novel forms of harm related to technology (eg, geofencing in domestic violence and errors related to interconnected fetal monitoring systems) and barriers impeding adverse event reporting (eg, time constraints and postmortem device disposal). Challenges to providing effective patient care included a lack of clinical suspicion of device failures, unfamiliarity with equipment, and an absence of digitally tailored clinical protocols. Participants agreed that cyberattacks should be classified as major incidents, with the repurposing of existing crisis resources. Treatment of patients was determined by the role technology played in clinical management, such that those reliant on potentially compromised laboratory or radiological facilities were prioritized.
    CONCLUSIONS: Here, we have framed digital events through a clinical lens, described in terms of their end-point impact on the patient. In doing so, we have developed a series of recommendations for ensuring responses to digital events are tailored to clinical needs and center patient care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    A whole series of processes lead to the decrease in the use of traditional medicine by the indigenous peoples of Mexico, including the reduction in the number of traditional healers and the direct and indirect expansion of biomedicine. This essay addresses the central role these processes play in the relations of hegemony/subalternity that occur in different fields of reality, and especially in the health-illness-care-prevention processes, given that counter-hegemonic processes are not generated, or those that do arise have been ineffective in confronting social hegemony in general and biomedical hegemony in particular.
    Toda una serie de procesos conducen a la disminución del uso de la medicina tradicional por los pueblos indígenas de México, incluyendo la reducción del número de curadores tradicionales y la expansión directa e indirecta de la biomedicina. En este ensayo se aborda el papel nuclear que tienen estos procesos en las relaciones de hegemonía/subaltenidad que se dan en los diferentes campos de la realidad y, especialmente, en los procesos de salud-enfermedad-atención-prevención, dado que no se generan procesos contrahegemónicos o, los que surgen, han sido ineficaces para enfrentar la hegemonía social en general y biomédica en particular.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本文通过生物医学视角评论毕加索的绘画《科学与慈善》(1897),反映了临床医学的发展。医学的两个灵魂,即冷酷的科学和富有同情心的科学,在他们的二分法以及他们与今天的治疗和福祉概念的关系中进行了研究。
    The present article reflects on the evolution of clinical medicine throughout time by commenting on Picasso\'s painting Science and Charity (1897) through a biomedical lens. The two souls of medicine, namely the cold scientific one and the compassionate one, are examined in their dichotomy and their relationship with today\'s concepts of cure and well-being.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号